Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1337 studies found for:    "Carcinoma, Squamous Cell"
Show Display Options
Rank Status Study
1 Recruiting Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
Conditions: Carcinoma, Squamous Cell of Head and Neck;   HPV Positive Oropharyngeal Squamous Cell Carcinoma;   Hypopharyngeal Cancer;   Early Invasive Cervical Squamous Cell Carcinoma;   Carcinoma of Larynx;   Cancer of Nasopharynx
Interventions: Drug: BKM120;   Drug: Cisplatin;   Radiation: Intensity-modulated radiotherapy (IMRT)
2 Not yet recruiting Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
Conditions: Cancer of Head and Neck;   Head and Neck Cancer;   Neoplasms, Head and Neck;   Carcinoma, Squamous Cell of Head and Neck;   Squamous Cell Carcinoma of the Head and Neck;   Squamous Cell Carcinoma, Head and Neck
Interventions: Biological: MK-3475;   Procedure: Surgery;   Radiation: Intensity modulated radiation therapy;   Radiation: Image-guided radiation therapy;   Drug: Cisplatin
3 Completed Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR
Conditions: Skin Diseases;   Carcinoma, Squamous Cell
Intervention: Drug: cetuximab
4 Terminated An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
Condition: Carcinoma, Squamous Cell
Intervention: Drug: Cetuximab
5 Recruiting Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Conditions: Carcinoma, Squamous Cell;   Head and Neck Neoplasms;   Oropharyngeal Neoplasms
Intervention: Other: Assessment of Oral HPV Infection
6 Terminated A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Neoplasms;   Carcinoma, Squamous Cell
Interventions: Drug: Surgery +(Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2;   Drug: (Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2+Surgery
7 Active, not recruiting De-intensification of Radiation and Chemotherapy for Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma
Conditions: Carcinoma, Squamous Cell;   Head and Neck Neoplasms;   Oropharyngeal Neoplasms
Interventions: Radiation: Intensity Modulated Radiotherapy (IMRT);   Drug: Cisplatin;   Procedure: Limited surgical evaluation
8 Withdrawn Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck
Conditions: Head and Neck Cancer;   Carcinoma, Squamous Cell
Interventions: Drug: Iressa (Gefitinib);   Procedure: Radiotherapy
9 Active, not recruiting Oral Rigosertib for Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma;   Anal Squamous Cell Carcinoma;   Lung Squamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Esophageal Squamous Cell Carcinoma
Intervention: Drug: rigosertib
10 Unknown  Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)
Condition: Carcinoma, Squamous Cell
Intervention: Drug: infusions of Panitumumab
11 Completed A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck
Conditions: Head and Neck Neoplasms;   Carcinoma, Squamous Cell
Intervention: Drug: ARQ 501
12 Terminated Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)
Conditions: Carcinoma, Squamous Cell;   Head and Neck Neoplasms
Intervention: Drug: Farnesyl Protein Transferase Inhibitor
13 Recruiting Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IVA Salivary Gland Cancer;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Salivary Gland Cancer;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Salivary Gland Cancer;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer;   Untreated Metastatic Squamous Neck Cancer With Occult Primary
Interventions: Drug: sorafenib tosylate;   Drug: cisplatin;   Drug: docetaxel;   Other: Correlative Studies
14 Completed Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer
Condition: Squamous Cell Cancer
Intervention: Drug: proflavine
15 Completed Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ
Condition: Carcinoma, Squamous Cell
Intervention: Drug: PEP005
16 Not yet recruiting Neck Dissection Via a Robot-assisted Transaxillary Approach in Patients With Squamous Cell Carcinoma of the Epi-larynx
Condition: Carcinoma, Squamous Cell
Intervention: Procedure: Neck Dissection
17 Completed
Has Results
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Cancer
Interventions: Drug: Imatinib Mesylate;   Drug: Docetaxel
18 Withdrawn A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck
Conditions: Head and Neck Neoplasms;   Squamous Cell Cancer
Intervention: Procedure: Intensity Modulated Radiotherapy
19 Completed A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer
Conditions: HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma;   HER2 + Breast Cancer;   HER2 + Gastric Cancer;   Squamous Cell Carcinoma of Head and Neck;   Esophageal Squamous Cell Carcinoma
Intervention: Drug: LJM716
20 Recruiting A Study to Evaluate the Safety and Efficacy of PC-A11 in Patients With Recurrent Head and Neck Squamous Cell Carcinoma
Conditions: Recurrent Head and Neck Neoplasms;   Recurrent Head and Neck Cancer;   Carcinoma, Squamous Cell of Head and Neck
Intervention: Drug: Amphinex induced PCI of bleomycin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years